The Cell and Gene Therapy Catapult is an independent innovation and technology organisation committed to the advancement of the CGT industry with a vision of a thriving industry delivering life changing advanced therapies to the world. Its aim is to create powerful collaborations which overcome challenges to the advancement of the sector. With around 300 experts covering all aspects of advanced therapies, it applies its unique capabilities and assets, collaborates with academia, industry and healthcare providers to develop new technology and innovation.

Website: https://ct.catapult.org.uk/

LinkedIn: https://www.linkedin.com/company/cgt-catapult/

MaxCyte® empowers innovative cell and gene therapy development and drug discovery through ExPERT™ Flow Electroporation® and SeQure™ genotoxicity assays. Supported by expert scientific and regulatory guidance for 25+ years, MaxCyte has advanced safe, effective treatments that are shaping the future of medicines. Learn more at www.maxcyte.com.

Driven by science and a passion for quality, STEMCELL Technologies offers over 2500 tools and services to support discoveries in fields such as immunotherapy, regenerative medicine, and disease research. Whether you’re culturing and editing hematopoietic stem and progenitor cells, differentiating pluripotent stem cells, or activating and expanding immune cells, we have specialized cell isolation products, high-performance cell culture media, and accessory tools for your research. By increasing the accessibility of innovative techniques like gene editing and organoid cultures, we’re helping scientists accelerate the pace of discovery—so they can get therapies to patients faster. Researchers working towards clinical trials can also obtain guidance and customized support through our Services for Cell Therapy Program on qualifying our products for use as raw/ancillary materials. To learn more, visit www.STEMCELL.com.

Promega is a global leader in providing innovative solutions and scientific expertise that support the development of cell and gene therapies. With a broad portfolio of high-quality reagents and assays, Promega enables researchers and developers to generate reliable, meaningful data across the CGT workflow—from early research through process development, manufacturing, and quality control

Designed to address the complexity of living therapies, Promega’s cell and gene therapy solutions support critical measurements of cell health, identity, potency, safety, and functionality. Backed by deep technical support and a collaborative approach, Promega partners with the CGT community to help accelerate the delivery of transformative therapies to patients.